BardyDx: After 'punch in mouth,' Hillrom will proceed with $367M deal to acquire Seattle's Bardy Diagnostics - NewsBreak

Update: Hillroom's acquisition of Bardy completed late in the day on Friday, according to an SEC filing. Medical device company Hillrom has called off its lawyers after initially backing out of a $367 million acquisition of Seattle startup Bardy Diagnostics. The deal to acquire Bardy will now proceed, said Hillrom CEO John Groetelaars in a call to investors July 30.